Corporate News – Guangzhou Kingmed Diagnostics
Market Performance (24 h ending 06:04 PM CET, Thursday 22 Oct 2026)
- Price: CNY 30.16
- Change: 0 % (flat)
- Volume: CNY 540.4 million of shares traded
- Supply: 463.9 million shares outstanding
- Market Capitalisation: CNY 14.4 billion
- 52‑week high: CNY 40.68 (13 Jan 2026)
- 52‑week low: CNY 21.50 (29 Jun 2026)
- SMA (200 days): CNY 26.87
- Year‑to‑date change: +6.81 %
Corporate Development On 9 October 2026 Guangzhou Kingmed Diagnostics announced the liquidation and dissolution of its Hong Kong‑based joint venture, DRA Company Limited, under the Hong Kong Companies Ordinance.
- Reason: Assessment of market conditions and limited commercial progress in high‑end non‑invasive prenatal testing.
- Financial impact: The venture’s shareholding, acquired in 2018 for RMB 1.5 billion, has been fully written down through impairment provisions over recent years. Management states the liquidation will not materially affect the parent company’s core operations or financial position.
- Strategic focus: Post‑liquidation, Guangzhou Kingmed will emphasize cost leadership, improved cash‑flow quality, and expansion of its specialised testing portfolio.
Related Stock Movements (Last 24 h)
| Stock | Exchange | 24‑h Change | Current Price | Market Cap | P/E (if available) |
|---|---|---|---|---|---|
| Beijing Haohua Energy Reso (601101.SS) | Shanghai | 0 % | CNY 11.66 | CNY 17.2 bn | 21.02 |
| Zhuzhou Hongda Electronics (300726.SZ) | Shenzhen | 0 % | CNY 40.30 | CNY 17.2 bn | 40.68 |
| Unicomp (688531.SS) | Shanghai | 0 % | CNY 97.02 | CNY 17.3 bn | — |
| Star Shine Ltd (1440.HK) | Hong Kong | -2.87 % | HKD 15.06 | HKD 20.2 bn | — |
| Joincare Pharmaceutical Group (600380.SS) | Shanghai | 0 % | CNY 9.22 | CNY 17.2 bn | 14.37 |
| Note: Joincare Pharmaceutical Group announced that its shares are now wholly owned by a single entity; no other investors hold a stake. |
Company Profile
- Name: Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Business: Medical laboratory services, including clinical testing, pathology diagnosis outsourcing, and related services.
- Clients: Hospitals, maternity and child health centres, health centres, and other medical institutions.
- Listing: Shanghai Stock Exchange.
- Website: https://www.kingmed.com.cn/
